Atherotech Diagnostics Lab Release: VAPĀ® Cholesterol Test Helps Researchers Study Dyslipidemia, Assess Effectiveness of New Anti-flushing Agent  
3/15/2012 10:05:37 AM

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Researchers using the VAPĀ® Cholesterol Test to isolate lipid subfractions and assess a new anti-flushing agent report significant baseline reductions in the cholesterol content of lipoproteins across the entire VLDL to LDL density range in dyslipidemic patients.